Although I’ve been blogging alot about dichloroacetate, the small molecule chemotherapeutic agent that has shown promise against a variety of cancers in preclinical animal tumor models, but I’m not the only one. Fellow ScienceBlogger Abel Pharmboy, whose knowledge of pharmacology surpasses my own, has also been on the case and has produced some articles worth […]
Category: Clinical trials
The longer I maintain this blog, the more I find unexpected (to me, at least) intersections and relationships between various topics that I write about. Of course, a lot of it simply has to do with the fact that one of the overarching themes of this blog is skepticism and critical thinking, which leads one […]
Share this:
Last week, I wrote a quick and (semi-) facetious piece about how my colleague and I are sweating to the NIH payline, as we wait to find out whether our R01 application will be funded or not. With its being rumored that National Cancer Institute (NCI) paylines will be in the range of the 12th […]
Share this:
One byproduct of blogging that I had never anticipated when I started is how it sometimes gets me interested in scientific questions that I would never have paid much attention to before or looked into other than superficially. One such scientific question is whether dichloroacetate (DCA), the small molecule that was shown to have significant […]
Share this:
I’ve probably beat this one into the ground over the last couple of days; so this will be uncharacteristically brief, because it’s time to move on. Also, it was fun to see DaveScot go into paroxysms to try to justify the dangerous, unethical, and reckless actions of Heather Nordstrom and her stepfather in setting up […]
